Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report released on Thursday morning. The firm issued a hold rating on the stock.

Retractable Technologies Price Performance

Shares of RVP stock opened at $0.74 on Thursday. The firm has a fifty day simple moving average of $0.78 and a 200-day simple moving average of $0.74. The company has a market capitalization of $22.16 million, a PE ratio of -1.37 and a beta of 2.08. Retractable Technologies has a twelve month low of $0.56 and a twelve month high of $1.22. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC raised its holdings in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the period. Renaissance Technologies LLC owned about 1.21% of Retractable Technologies worth $249,000 as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.